Indraprastha Medical Corporation Limited is an India-based company engaged in the healthcare business. The business activities of the Company are running and operating hospitals, which include Indraprastha Apollo Hospitals and Apollo Hospitals. Indraprastha Apollo Hospitals is a multi-specialty tertiary acute care hospital with approximately 710 beds and is spread over 15 acres and has a built-up area of over 600,000 square feet. It has approximately 52 specialties under one roof with the major specialties being anesthesia, cardiology, cardiac surgery, cancer, pediatrics, critical care, emergency care, fetal medicine, gastroenterology and hepatology, obstetrics & gynecology, interventional radiology, IVF, liver and kidney transplant, nuclear medicine, nephrology, neurosciences, ophthalmology, orthopedics, otolaryngology (ENT), pediatrics, pediatric surgery, psychiatry and clinical psychology, rheumatology, spine surgery, urology and andrology and vascular and endovascular surgery.
Indraprastha Medical Corporation Ltd FAQs
How to Buy Indraprastha Medical Corporation Ltd Share?
To purchase Indraprastha Medical Corporation Ltd shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Indraprastha Medical Corporation Ltd (ticker symbol: INDRAMEDCO) on the trading platform provided by your broker and purchase the shares.
What's Indraprastha Medical Corporation Ltd share price today?
The stock price of Indraprastha Medical Corporation Ltd as of 07 Oct 2025 is ₹567.64
What is the Market Cap of Indraprastha Medical Corporation Ltd?
Market capitalisation represents the total market value of a company's outstanding shares. As of 07 Oct 2025, Indraprastha Medical Corporation Ltd (ticker symbol: INDRAMEDCO) has a market capitalisation of approximately ₹42,40,00,00,000.00
What is the PE and PB ratio of Indraprastha Medical Corporation Ltd?
Indraprastha Medical Corporation Ltd Ltd's price-to-book ratio as of 07 Oct 2025 is 8.72, reflecting the market's valuation compared to its asset value. As of 07 Oct 2025, the trailing twelve months P/E (price-to-earnings) ratio is 32.33, indicating the market values the company at around ₹32.33 for every ₹1 of earnings
What is the 52 Week High and Low of Indraprastha Medical Corporation Ltd Share?
Indraprastha Medical Corporation Ltd Ltd (INDRAMEDCO) hit its 52-week high at ₹572.00, and its 52-week low at ₹307.25.